@Article{Boguradzki2001,
journal="Contemporary Oncology/Współczesna Onkologia",
issn="1428-2526",
volume="5",
number="4",
year="2001",
title="The use of monoclonal antibody in treatment of indolent non-Hodgkin\’s lymphoma",
abstract="Indolent non-Hodgkin\’s lymphoma (iNHL) create difficult therapeutic problem. Because of insufficient effectiveness and excessive toxicity a search for new treatment modalities continues. Humanised monoclonal antibodies against surface molecules of neoplastic cells represent therapeutic alternative with distinct mechanism of action and not overlapping toxicity with cytostatic agents. They are currently used in indolent NHL as a sole treatment and in combination with cytotastics. Moreover, they are conjugated with toxins or radioisotopes to enhance their cytotoxic activity. Their additional combination with hematopoietic transplantation may soon provide a cure for indolent NHL.",
author="Boguradzki, Piotr",
pages="156--160",
url="https://www.termedia.pl/The-use-of-monoclonal-antibody-in-treatment-of-indolent-non-Hodgkin-8217-s-lymphoma,3,614,1,1.html"
}